[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598734":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":18,"responsibleParty":38,"collaborators":40,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":59,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"American Heart Association","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Direct-to-Participant Group",null,"Observational",[13],"Other: None - Observational study",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"None - Observational study",[9],[19],{"facility":5,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Dallas","Texas","75231","United States","US",{"type":27,"coordinates":28},"Point",[29,30],-96.80667,32.78306,{"lat":30,"lon":29},[33],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"HLBW Study Team","CONTACT","888-242-2222","AHA.HLBW@heart.org",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[41,44,46],{"name":42,"class":43},"Evidation Health","INDUSTRY",{"name":45,"class":6},"Duke Clinical Research Institute",{"name":47,"class":6},"Johns Hopkins University","100598734","healthy-living-beyond-weight-study-100598734",false,"NCT07075341","Healthy Living BEYOND Weight Study","Inclusion Criteria:\n\n* BMI at the time of enrollment of 25 kg\u002Fm2 or greater or other elevated adiposity measures (e.g., waist circumference of greater than 102cm (40 in) in men or 88cm (35 in) in women) OR adults with a BMI less than 25 due to previous or current weight management treatment (lifestyle, pharmacological or surgical).\n\nExclusion Criteria:\n\n* Incarcerated at the time of enrollment\n* Self-reported pregnancy at the time of enrollment. However, individuals who become pregnant after enrollment will be welcomed to continue to participate, given that the critical life period of pregnancy often has a significant impact on subsequent weight trajectories.\n* Terminal illness or end-stage disease with a life expectancy of less than 6-months\n* Employed by the American Heart Association or working on the Healthy Living BEYOND Weight Study","ALL","18 Years",{"count":57,"type":58},1000000,"ESTIMATED","10 Years","OBSERVATIONAL","The Healthy Living BEYOND Weight Study is an observational research study of participants living with overweight and obesity. The principal objectives for this project will be to answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity, and to assess the real-world effectiveness of different weight management strategies, within contemporary and diverse populations. To accomplish this, the Study Team for this project will leverage their expertise in the science of obesity and cardiometabolic health; epidemiology, cohort and registry studies; implementation science; cardiovascular prevention and management; and disparities and community-based research to lead the development of an innovative cohort of people living with overweight or obesity with two key components:\n\n1. patient-report data elements, obtained through surveys;\n2. linkage to EHR records providing data regarding clinical encounters.\n\nThe cohort will be inclusive, comprehensive, and constructed with scientific rigor as well as high internal and external validity. An overall objective is for the Healthy Living BEYOND Weight Study is to serve as an enduring resource for researchers studying the health consequences of obesity and evaluating the impact of weight management strategies.",[63],"Overweight or Obesity",[65,66,67,68,69,70,71,72,73,74,75,76,77],"overweight","obesity","weight management","BMI","cardiovascular disease","Cardiovascular-Kidney Metabolic","CVD","CKM","GLP-1 RA","glucagon-like peptide-1","GLP-1","GLP-1 receptor agonists","bariatric","2025-08-01",{"date":80,"type":81},"2025-08-06","ACTUAL",{"date":83,"type":81},"2025-06-30",{"date":85,"type":58},"2060-12",{"name":5,"class":6},1]